Skip to main content
SpringerLink
Log in

Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Variants of glucocorticoid induced transcript 1 (GLCCI1) result decreased response to inhaled corticosteroids, while intronic variant of low-affinity IgE receptor (FCER2) is associated with exacerbation rates in children with asthma. We examined the ethnic differences, allele and genotype frequencies of two linked single nucleotide polymorphisms (rs37972, rs37973) of GLCCI1 and rs28364072 intronic variant of FCER2 gene in average Roma and Hungarian population. A study population of 474 healthy Roma and 397 Hungarian subjects were characterized for GLCCI1 and FCER2 polymorphisms using real time polymerase chain reaction (PCR) assay and PCR-restriction fragment length polymorphism method. The rs37972 and rs37973 polymorphisms in GLCCI1 were found in 100 % linkage disequilibrium both in Romas and in Hungarians. We found significant differences between the two groups regarding both minor allele frequencies (54.5 vs. 43.8 %, p ≤ 0.01) and homozygous genotype (31.6 vs. 21.3 %, p ≤ 0.01) of GLCCI1. For FCER2 rs28364072 the homozygous variant genotype was present in 2.8 % in Romas, while in Hungarians it was 5.8 % (p = 0.032). The opposite changes of these two polymorphisms strongly suggest that contrary current belief analyses of GLCCI1 variants are insufficient for personalised glucocorticoid therapies in different populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mukherjee AB, Zhang Z (2011) Allergic asthma: influence of genetic and environmental factors. J Biol Chem 286(38):32883–32889. doi:10.1074/jbc.R110.197046

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Pascual RM, Bleecker ER (2010) Pharmacogenetics of asthma. Curr Opin Pharmacol 10(3):226–235. doi:10.1016/j.coph.2010.05.013

    Article  PubMed  CAS  Google Scholar 

  3. Drazen JM, Silverman EK, Lee TH (2000) Heterogeneity of therapeutic responses in asthma. Br Med Bull 56(4):1054–1070

    Article  PubMed  CAS  Google Scholar 

  4. Kazani S, Wechsler ME, Israel E (2010) The role of pharmacogenomics in improving the management of asthma. J Allergy Clin Immunol 125 (2):295–302; quiz 303-294. doi: 10.1016/j.jaci.2009.12.014

  5. Tantisira KG, Lasky-Su J, Harada M, Murphy A, Litonjua AA, Himes BE, Lange C, Lazarus R, Sylvia J, Klanderman B, Duan QL, Qiu W, Hirota T, Martinez FD, Mauger D, Sorkness C, Szefler S, Lazarus SC, Lemanske RF Jr, Peters SP, Lima JJ, Nakamura Y, Tamari M, Weiss ST (2011) Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 365(13):1173–1183. doi:10.1056/NEJMoa0911353

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Cheong HI, Kang HG, Schlondorff J (2012) GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome. Pediatr Nephrol 27(9):1595–1599. doi:10.1007/s00467-012-2197-6

    Article  PubMed  PubMed Central  Google Scholar 

  7. Maitland-van der Zee AH, Raaijmakers JA (2012) Variation at GLCCI1 and FCER2: one step closer to personalized asthma treatment. Pharmacogenomics 13(3):243–245. doi:10.2217/pgs.11.177

    Article  PubMed  CAS  Google Scholar 

  8. Acharya M, Borland G, Edkins AL, Maclellan LM, Matheson J, Ozanne BW, Cushley W (2010) CD23/FcepsilonRII: molecular multi-tasking. Clin Exp Immunol 162(1):12–23. doi:10.1111/j.1365-2249.2010.04210.x

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Okun E, Mattson MP, Arumugam TV (2010) Involvement of Fc receptors in disorders of the central nervous system. Neuromolecular Med 12(2):164–178. doi:10.1007/s12017-009-8099-5

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125(2 Suppl 2):S73–S80. doi:10.1016/j.jaci.2009.11.017

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rosenwasser LJ, Meng J, Chan MA, Gigliotti NM, May BE (2011) The role of CD23 in IgE dependent signaling: implications from pharmacogenetics. Trans Am Clin Climatol Assoc 122:27–33

    PubMed  PubMed Central  Google Scholar 

  12. Vercelli D, Jabara HH, Lee BW, Woodland N, Geha RS, Leung DY (1988) Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med 167(4):1406–1416

    Article  PubMed  CAS  Google Scholar 

  13. Tse SM, Tantisira K, Weiss ST (2010) The pharmacogenetics and pharmacogenomics of asthma therapy. Pharmacogenomics J 11(6):383–392. doi:10.1038/tpj.2011.46

    Article  Google Scholar 

  14. Tantisira KG, Silverman ES, Mariani TJ, Xu J, Richter BG, Klanderman BJ, Litonjua AA, Lazarus R, Rosenwasser LJ, Fuhlbrigge AL, Weiss ST (2007) FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 120(6):1285–1291. doi:10.1016/j.jaci.2007.09.005

    Article  PubMed  CAS  Google Scholar 

  15. Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmuller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, Beeson D, Venkataraman V, Warwick Carter K, Reeve J, de Pablo R, Kucinskas V, Kalaydjieva L (2004) Mutation history of the roma/gypsies. Am J Hum Genet 75(4):596–609. doi:10.1086/424759

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Gresham D, Morar B, Underhill PA, Passarino G, Lin AA, Wise C, Angelicheva D, Calafell F, Oefner PJ, Shen P, Tournev I, de Pablo R, Kucinskas V, Perez-Lezaun A, Marushiakova E, Popov V, Kalaydjieva L (2001) Origins and divergence of the Roma (gypsies). Am J Hum Genet 69(6):1314–1331. doi:10.1086/324681

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Kalaydjieva L, Gresham D, Calafell F (2001) Genetic studies of the Roma (Gypsies): a review. BMC Med Genet 2:5

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Zeman CL, Depken DE, Senchina DS (2003) Roma health issues: a review of the literature and discussion. Ethn Health 8(3):223–249. doi:10.1080/1355785032000136434

    Article  PubMed  Google Scholar 

  19. Muscat M (2011) Who gets measles in Europe? J Infect Dis 204(Suppl 1):S353–S365. doi:10.1093/infdis/jir067

    Article  PubMed  Google Scholar 

  20. Masseria C, Mladovsky P, Hernandez-Quevedo C (2010) The socio-economic determinants of the health status of Roma in comparison with non-Roma in Bulgaria, Hungary and Romania. Eur J Public Health 20(5):549–554. doi:10.1093/eurpub/ckq102

    Article  PubMed  Google Scholar 

  21. http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=19:7754785-7755785;v=rs28364072;vdb=variation;vf=100595325 http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=19:7754785-7755785;v=rs28364072;vdb=variation;vf=100595325

  22. http://alfred.med.yale.edu/alfred/SiteTable1A_working.asp?siteuid=SI391198F http://alfred.med.yale.edu/alfred/SiteTable1A_working.asp?siteuid=SI391198F

Download references

Acknowledgments

This work was supported by the grant of the Hungarian Science Foundation OTKA K103983.

Conflict of interest

The authors declare that they have no conflict interest.

Author information

Authors and Affiliations

  1. Department of Medical Genetics, University of Pecs, Szigeti 12, Pecs, 7624, Hungary

    Renata Szalai, Petra Matyas, Marton Melegh, Lili Magyari, Luca Jaromi, Katalin Sumegi, Balazs Duga, Erzsebet Kovesdi, Kinga Hadzsiev & Bela Melegh

  2. Szentagothai Research Centre, University of Pecs, Ifjusag 20, Pecs, 7624, Hungary

    Renata Szalai, Lili Magyari, Luca Jaromi, Balazs Duga, Erzsebet Kovesdi & Bela Melegh

  3. Department of Dermatology, Venereology and Oncodermatology, University of Pecs, Kodaly Z. 20, Pecs, 7624, Hungary

    Dalma Varszegi

Authors
  1. Renata Szalai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Petra Matyas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dalma Varszegi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marton Melegh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lili Magyari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luca Jaromi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katalin Sumegi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Balazs Duga
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Erzsebet Kovesdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kinga Hadzsiev
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Bela Melegh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bela Melegh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szalai, R., Matyas, P., Varszegi, D. et al. Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids. Mol Biol Rep 41, 7665–7669 (2014). https://doi.org/10.1007/s11033-014-3659-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3659-7

Keywords

Search

Navigation